These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12358520)

  • 1. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors.
    Dales NA; Gould AE; Brown JA; Calderwood EF; Guan B; Minor CA; Gavin JM; Hales P; Kaushik VK; Stewart M; Tummino PJ; Vickers CS; Ocain TD; Patane MA
    J Am Chem Soc; 2002 Oct; 124(40):11852-3. PubMed ID: 12358520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme-2: a molecular and cellular perspective.
    Warner FJ; Smith AI; Hooper NM; Turner AJ
    Cell Mol Life Sci; 2004 Nov; 61(21):2704-13. PubMed ID: 15549171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The interconnection between the activity of carboxypeptidase N and angiotensin-converting enzyme].
    Vernigora AN; Nikishin NN; Gengin MT
    Biokhimiia; 1995 Jan; 60(1):144-9. PubMed ID: 7696431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of histargin and related compounds and their inhibition of enzymes.
    Moriguchi M; Umeda Y; Miyazaki K; Nakamura T; Ogawa K; Kojima F; Iinuma H; Aoyagi T
    J Antibiot (Tokyo); 1988 Dec; 41(12):1823-7. PubMed ID: 3209475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
    Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
    J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel peptide inhibitors of angiotensin-converting enzyme 2.
    Huang L; Sexton DJ; Skogerson K; Devlin M; Smith R; Sanyal I; Parry T; Kent R; Enright J; Wu QL; Conley G; DeOliveira D; Morganelli L; Ducar M; Wescott CR; Ladner RC
    J Biol Chem; 2003 May; 278(18):15532-40. PubMed ID: 12606557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis.
    Towler P; Staker B; Prasad SG; Menon S; Tang J; Parsons T; Ryan D; Fisher M; Williams D; Dales NA; Patane MA; Pantoliano MW
    J Biol Chem; 2004 Apr; 279(17):17996-8007. PubMed ID: 14754895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.
    Ferrario CM; Jessup J; Chappell MC; Averill DB; Brosnihan KB; Tallant EA; Diz DI; Gallagher PE
    Circulation; 2005 May; 111(20):2605-10. PubMed ID: 15897343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite.
    Deaton DN; Graham KP; Gross JW; Miller AB
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1681-7. PubMed ID: 18243695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors.
    Turner AJ; Tipnis SR; Guy JL; Rice G; Hooper NM
    Can J Physiol Pharmacol; 2002 Apr; 80(4):346-53. PubMed ID: 12025971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
    J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
    Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
    Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite.
    Deaton DN; Gao EN; Graham KP; Gross JW; Miller AB; Strelow JM
    Bioorg Med Chem Lett; 2008 Jan; 18(2):732-7. PubMed ID: 18078750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors.
    Jallapally A; Addla D; Bagul P; Sridhar B; Banerjee SK; Kantevari S
    Bioorg Med Chem; 2015 Jul; 23(13):3526-33. PubMed ID: 25922179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean.
    Takahashi S; Yoshiya T; Yoshizawa-Kumagaye K; Sugiyama T
    Biomed Res; 2015; 36(3):219-24. PubMed ID: 26106051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.
    Vickers C; Hales P; Kaushik V; Dick L; Gavin J; Tang J; Godbout K; Parsons T; Baronas E; Hsieh F; Acton S; Patane M; Nichols A; Tummino P
    J Biol Chem; 2002 Apr; 277(17):14838-43. PubMed ID: 11815627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
    Natesh R; Schwager SL; Sturrock ED; Acharya KR
    Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
    Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
    Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
    Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
    Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.